Table 2.
Acceptability and effectiveness of targeted versus blanket PITC in three hospitals in Cameroon, ASPA study, July 2015–November 2016
| Outcome | tPITC | bPITC | P* | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Limbe | Abong-Mbang | Ndop | Total | Limbe | Abong-Mbang | Ndop | Total | ||
| % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | ||
| Acceptability rate | 100.0 (327/327) | 99.7 (344/345) | 99.6 (566/568) | 99.8 (1616/1619) | 99.2 (1013/1021) | 99.3 (575/579) | 98.0 (842/859) | 98.8 (2430/2459) | 0.0005 |
| Feasibility rate | 54.3 (300/552) | 88.0 (352/400) | 46.0 (477/1038) | 56.7 (1129/1990) | 78.9 (951/1205) | 99.4 (619/623) | 99.3 (895/901) | 90.3 (2465/2729) | < 0.0001 |
| HIV positivity rate | 1.7 (5/300) | 4.0 (14/352) | 4.4 (21/477) | 3.5 (40/1129) | 1.5 (14/951) | 3.4 (21/619) | 0.6 (5/895) | 1.6 (40/2465) | 0.0008 |
| Linkage rate | 20.0 (1/5) | 92.9 (12/14) | 95.2 (20/21) | 85.0 (33/40) | 21.4 (3/14) | 76.2 (16/21) | 40.0 (2/5) | 52.5 (21/40) | 0.0018 |
*p value comparing the outcome (total) of tPITC vs. bPITC in the 3 study sites